CAR T Cell Therapy’s Potential for Pediatric Brain Tumors
Malignant central nervous system tumors are the leading cause of cancer death in children. Progress in high-throughput molecular techniques has increased the molecular understanding of these tumors, but the outcomes are still poor. Even when efficacious, surgery, radiation, and chemotherapy cause ne...
Saved in:
Main Authors: | Pauline Thomas, Natacha Galopin, Emma Bonérandi, Béatrice Clémenceau, Sophie Fougeray, Stéphane Birklé |
---|---|
Format: | article |
Language: | EN |
Published: |
MDPI AG
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/ae313db6a6094e169834075363a59a1f |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Growing Relevance of Immunoregulation in Pediatric Brain Tumors
by: Viktoria Melcher, et al.
Published: (2021) -
An atypical teratoid/rhabdoid tumor (AT/RT) with molecular features of pleomorphic xanthoastrocytoma (PXA) in a 62-year-old patient
by: Matthias Dottermusch, et al.
Published: (2021) -
The impact of magnetic resonance imaging spectroscopy parameters on differentiating between paediatric medulloblastoma and ependymoma
by: Nguyen Minh Duc
Published: (2021) -
Liquid Biopsy and Primary Brain Tumors
by: Robert H. Eibl, et al.
Published: (2021) -
CAR-T and other adoptive cell therapies for B cell malignancies
by: Peihua Lu, et al.
Published: (2021)